Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China flag China · Delayed Price · Currency is CNY
25.70
-0.15 (-0.58%)
At close: Mar 9, 2026

SHE:300204 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 2019 - 2015
Market Capitalization
12,2793,5404,8546,4198,2424,241
Upgrade
Market Cap Growth
248.24%-27.07%-24.38%-22.12%94.35%-18.80%
Upgrade
Enterprise Value
12,1523,4984,7116,1137,8063,550
Upgrade
Last Close Price
25.707.4110.1613.6017.559.03
Upgrade
Forward PE
-78.5078.5078.5078.5078.50
Upgrade
PS Ratio
50.2510.9013.3311.6914.119.97
Upgrade
PB Ratio
14.283.864.764.745.322.67
Upgrade
P/TBV Ratio
15.084.055.035.125.702.86
Upgrade
EV/Sales Ratio
49.7310.7712.9411.1413.368.35
Upgrade
EV/FCF Ratio
-68.52-----
Upgrade
Debt / Equity Ratio
0.050.050.040.020.010.03
Upgrade
Net Debt / Equity Ratio
-0.13-0.01-0.04-0.17-0.30-0.42
Upgrade
Net Debt / EBITDA Ratio
2.050.510.131.172.234.35
Upgrade
Net Debt / FCF Ratio
0.660.130.171.022.104.13
Upgrade
Asset Turnover
0.190.260.240.310.320.23
Upgrade
Inventory Turnover
2.132.893.754.643.691.74
Upgrade
Quick Ratio
1.650.610.711.963.184.09
Upgrade
Current Ratio
2.461.151.152.283.504.34
Upgrade
Return on Equity (ROE)
-18.63%-15.25%-33.60%-13.56%-8.76%-8.25%
Upgrade
Return on Assets (ROA)
-3.55%-2.24%-15.56%-8.36%-8.13%-6.38%
Upgrade
Return on Invested Capital (ROIC)
-8.74%-4.73%-35.68%-21.17%-23.89%-21.02%
Upgrade
Return on Capital Employed (ROCE)
-6.30%-4.50%-33.20%-16.30%-14.70%-11.50%
Upgrade
Earnings Yield
-1.35%-4.09%-8.22%-3.07%-1.67%-3.14%
Upgrade
FCF Yield
-1.44%-2.46%-5.37%-3.62%-2.65%-3.85%
Upgrade
Buyback Yield / Dilution
-9.55%-1.67%1.17%-1.42%0.27%-4.41%
Upgrade
Total Shareholder Return
-9.55%-1.67%1.17%-1.42%0.27%-4.41%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.